IMDx is an innovative company that designs, develops and manufactures molecular diagnostic products. IMDx has developed molecular test solutions that are clinically impactful and competitively differentiated for a range of disease areas for current and next generation systems, including targets in infectious diseases, oncology and genetics.

IMDx produces molecular diagnostic test solutions under FDA QSR, ISO 13485:2003 and IVDD regulations and guidances for use in CLIA registered clinical reference laboratories. IMDx’s expertise spans evolutionary biology, bioinformatics, microbiology, chemistry and molecular biology. These capabilities are harnessed by our proprietary product development process allowing for the rapid design and development of tests to meet clinical needs. More»